Cargando…

Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay

OBJECTIVES: Detection of α‐synuclein aggregates by seed amplification is a promising Parkinson disease biomarker assay. Understanding intraindividual relationships of α‐synuclein measures could inform optimal biomarker development. The objectives were to test accuracy of α‐synuclein seed amplificati...

Descripción completa

Detalles Bibliográficos
Autores principales: Chahine, Lana M., Beach, Thomas G., Adler, Charles H., Hepker, Monica, Kanthasamy, Anumantha, Appel, Scott, Pritzkow, Sandra, Pinho, Michelle, Mosovsky, Sherri, Serrano, Geidy E., Coffey, Christopher, Brumm, Michael C., Oliveira, Luis M. A., Eberling, Jamie, Mollenhauer, Brit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187727/
https://www.ncbi.nlm.nih.gov/pubmed/36972727
http://dx.doi.org/10.1002/acn3.51753
_version_ 1785042791056801792
author Chahine, Lana M.
Beach, Thomas G.
Adler, Charles H.
Hepker, Monica
Kanthasamy, Anumantha
Appel, Scott
Pritzkow, Sandra
Pinho, Michelle
Mosovsky, Sherri
Serrano, Geidy E.
Coffey, Christopher
Brumm, Michael C.
Oliveira, Luis M. A.
Eberling, Jamie
Mollenhauer, Brit
author_facet Chahine, Lana M.
Beach, Thomas G.
Adler, Charles H.
Hepker, Monica
Kanthasamy, Anumantha
Appel, Scott
Pritzkow, Sandra
Pinho, Michelle
Mosovsky, Sherri
Serrano, Geidy E.
Coffey, Christopher
Brumm, Michael C.
Oliveira, Luis M. A.
Eberling, Jamie
Mollenhauer, Brit
author_sort Chahine, Lana M.
collection PubMed
description OBJECTIVES: Detection of α‐synuclein aggregates by seed amplification is a promising Parkinson disease biomarker assay. Understanding intraindividual relationships of α‐synuclein measures could inform optimal biomarker development. The objectives were to test accuracy of α‐synuclein seed amplification assay in central (cerebrospinal fluid) and peripheral (submandibular gland) sources, compare to total α‐synuclein measures, and investigate within‐subject relationships. METHODS: The Systemic Synuclein Sampling Study aimed to characterize α‐synuclein in multiple tissues and biofluids within Parkinson disease subjects (n = 59) and compared to healthy controls (n = 21). Motor and non‐motor measures and dopamine transporter scans were obtained. Four measures of α‐synuclein were compared: seed amplification assay in cerebrospinal fluid and formalin‐fixed paraffin‐embedded submandibular gland, total α‐synuclein quantified in biofluids using enzyme‐linked immunoassay, and aggregated α‐synuclein in submandibular gland detected by immunohistochemistry. Accuracy of seed amplification assay for Parkinson disease diagnosis was examined and within‐subject α‐synuclein measures were compared. RESULTS: Sensitivity and specificity of α‐synuclein seed amplification assay for Parkinson disease diagnosis was 92.6% and 90.5% in cerebrospinal fluid, and 73.2% and 78.6% in submandibular gland, respectively. 25/38 (65.8%) Parkinson disease participants were positive for both cerebrospinal fluid and submandibular gland seed amplification assay. Comparing accuracy for Parkinson disease diagnosis of different α‐synuclein measures, cerebrospinal fluid seed amplification assay was the highest (Youden Index = 83.1%). 98.3% of all Parkinson disease cases had ≥1 measure of α‐synuclein positive. INTERPRETATION: α‐synuclein seed amplification assay (cerebrospinal fluid>submandibular gland) had higher sensitivity and specificity compared to total α‐synuclein measures, and within‐subject relationships of central and peripheral α‐synuclein measures emerged.
format Online
Article
Text
id pubmed-10187727
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101877272023-05-17 Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay Chahine, Lana M. Beach, Thomas G. Adler, Charles H. Hepker, Monica Kanthasamy, Anumantha Appel, Scott Pritzkow, Sandra Pinho, Michelle Mosovsky, Sherri Serrano, Geidy E. Coffey, Christopher Brumm, Michael C. Oliveira, Luis M. A. Eberling, Jamie Mollenhauer, Brit Ann Clin Transl Neurol Research Articles OBJECTIVES: Detection of α‐synuclein aggregates by seed amplification is a promising Parkinson disease biomarker assay. Understanding intraindividual relationships of α‐synuclein measures could inform optimal biomarker development. The objectives were to test accuracy of α‐synuclein seed amplification assay in central (cerebrospinal fluid) and peripheral (submandibular gland) sources, compare to total α‐synuclein measures, and investigate within‐subject relationships. METHODS: The Systemic Synuclein Sampling Study aimed to characterize α‐synuclein in multiple tissues and biofluids within Parkinson disease subjects (n = 59) and compared to healthy controls (n = 21). Motor and non‐motor measures and dopamine transporter scans were obtained. Four measures of α‐synuclein were compared: seed amplification assay in cerebrospinal fluid and formalin‐fixed paraffin‐embedded submandibular gland, total α‐synuclein quantified in biofluids using enzyme‐linked immunoassay, and aggregated α‐synuclein in submandibular gland detected by immunohistochemistry. Accuracy of seed amplification assay for Parkinson disease diagnosis was examined and within‐subject α‐synuclein measures were compared. RESULTS: Sensitivity and specificity of α‐synuclein seed amplification assay for Parkinson disease diagnosis was 92.6% and 90.5% in cerebrospinal fluid, and 73.2% and 78.6% in submandibular gland, respectively. 25/38 (65.8%) Parkinson disease participants were positive for both cerebrospinal fluid and submandibular gland seed amplification assay. Comparing accuracy for Parkinson disease diagnosis of different α‐synuclein measures, cerebrospinal fluid seed amplification assay was the highest (Youden Index = 83.1%). 98.3% of all Parkinson disease cases had ≥1 measure of α‐synuclein positive. INTERPRETATION: α‐synuclein seed amplification assay (cerebrospinal fluid>submandibular gland) had higher sensitivity and specificity compared to total α‐synuclein measures, and within‐subject relationships of central and peripheral α‐synuclein measures emerged. John Wiley and Sons Inc. 2023-03-27 /pmc/articles/PMC10187727/ /pubmed/36972727 http://dx.doi.org/10.1002/acn3.51753 Text en © 2023 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Chahine, Lana M.
Beach, Thomas G.
Adler, Charles H.
Hepker, Monica
Kanthasamy, Anumantha
Appel, Scott
Pritzkow, Sandra
Pinho, Michelle
Mosovsky, Sherri
Serrano, Geidy E.
Coffey, Christopher
Brumm, Michael C.
Oliveira, Luis M. A.
Eberling, Jamie
Mollenhauer, Brit
Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay
title Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay
title_full Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay
title_fullStr Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay
title_full_unstemmed Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay
title_short Central and peripheral α‐synuclein in Parkinson disease detected by seed amplification assay
title_sort central and peripheral α‐synuclein in parkinson disease detected by seed amplification assay
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187727/
https://www.ncbi.nlm.nih.gov/pubmed/36972727
http://dx.doi.org/10.1002/acn3.51753
work_keys_str_mv AT chahinelanam centralandperipheralasynucleininparkinsondiseasedetectedbyseedamplificationassay
AT beachthomasg centralandperipheralasynucleininparkinsondiseasedetectedbyseedamplificationassay
AT adlercharlesh centralandperipheralasynucleininparkinsondiseasedetectedbyseedamplificationassay
AT hepkermonica centralandperipheralasynucleininparkinsondiseasedetectedbyseedamplificationassay
AT kanthasamyanumantha centralandperipheralasynucleininparkinsondiseasedetectedbyseedamplificationassay
AT appelscott centralandperipheralasynucleininparkinsondiseasedetectedbyseedamplificationassay
AT pritzkowsandra centralandperipheralasynucleininparkinsondiseasedetectedbyseedamplificationassay
AT pinhomichelle centralandperipheralasynucleininparkinsondiseasedetectedbyseedamplificationassay
AT mosovskysherri centralandperipheralasynucleininparkinsondiseasedetectedbyseedamplificationassay
AT serranogeidye centralandperipheralasynucleininparkinsondiseasedetectedbyseedamplificationassay
AT coffeychristopher centralandperipheralasynucleininparkinsondiseasedetectedbyseedamplificationassay
AT brummmichaelc centralandperipheralasynucleininparkinsondiseasedetectedbyseedamplificationassay
AT oliveiraluisma centralandperipheralasynucleininparkinsondiseasedetectedbyseedamplificationassay
AT eberlingjamie centralandperipheralasynucleininparkinsondiseasedetectedbyseedamplificationassay
AT mollenhauerbrit centralandperipheralasynucleininparkinsondiseasedetectedbyseedamplificationassay
AT centralandperipheralasynucleininparkinsondiseasedetectedbyseedamplificationassay